Connect with us

Halcion (triazolam)

Triazolam (or HALCION®) is mainly prescribed to treat insomnia.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1982

Dosage Forms: .125 mg, .25 mg

Biological Half-life: 1.5-5.5 hours

Side Effects: Dizziness, sleepiness, blurred vision, poor concentration, amnesia, slurred speech, lack of coordination

Serious Risks: Should NOT be taken during pregnancy

Routes of Administration: Oral

Pregnancy Category: X (US)


© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.